[Treatment and follow-up of thyroid cancer].
Välimäki
M
M
HYKS:n III sisätautien klinikka, Helsinki, Finland.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002116:Calcitonin / Q000097:blood; D002272:Carcinoembryonic Antigen / Q000097:blood; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008297:Male; D013954:Thyroglobulin / Q000097:blood; D013964:Thyroid Neoplasms / Q000097:blood / Q000628:therapy*; D013965:Thyroidectomy
D000970:Antineoplastic Agents; D002272:Carcinoembryonic Antigen; D007457:Iodine Radioisotopes; D002116:Calcitonin; D013954:Thyroglobulin
Kilpirauhassyövän hoito ja seuranta.